Similarly, receptor tyrosine kinase-Ras-Raf pathway activating mutations are significantly mutually exclusive in lung adenocarcinoma, and recurrent NF1 losses are enriched in samples lacking an activated oncogene13. The gene discussed is NTRK1; the disease is lung adenocarcinoma.